Study Evaluating Bifeprunox in Bipolar Depression

NCT00134459 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

434

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: Bifeprunox
DRUG: Placebo

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer

Collaborators

[object Object]